Live attenuated lentivirus infection elicits polyfunctional simian immunodeficiency virus Gag-specific CD8+ T cells with reduced apoptotic susceptibility in rhesus macaques that control virus replication after challenge with pathogenic SIVmac239

Journal of Immunology

Volumn 179, Issue 7, 2007, Pages 4732-4740

  Genescà, Meritxell ^a,b   Rourke, Tracy ^a,b   Li, Jun ^a,b   Bost, Kristen ^a,b   Chohan, Barinderpaul ^a,b   McChesney, Michael B ^b   Miller, Christopher J ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIPOCORTIN 5; LIVE VACCINE; PROTEIN BCL 2; SIMIAN HUMAN IMMUNODEFICIENCY VIRUS VACCINE; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; EFFECTOR CELL; IMMUNOPHENOTYPING; LYMPHOCYTE DIFFERENTIATION; MALE; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SURVIVAL; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE SUSCEPTIBILITY; GENE PRODUCTS, GAG; IMMUNOLOGIC MEMORY; LENTIVIRUS INFECTIONS; MACACA MULATTA; MALE; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA VIRUSES; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 40149085518     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.7.4732     Document Type: Article

References (35)

1. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68: 4650-4655.
2. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68: 6103-6110.
3. Kuroda, M. J., J. E. Schmitz, W. A. Charini, C. E. Nickerson, M. A. Lifton, C. I. Lord, M. A. Forman, and N. L. Letvin. 1999. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J. Immunol. 162: 5127-5133.
4. + lymphocytes. Science 283: 857-860.
5. + T cell depletion in simian immunodeficiency virusinfected macaques. J. Exp. Med. 189: 991-998.
6. + T cells. Blood 107: 4781-4789.
7. + T lymphocytes in vaccinated, simian human immunodeficiency virus-infected rhesus monkeys. J. Immunol. 176: 5338-5345.
8. + T cells in chronic human immunodeficiency virus infection. Blood 96: 3094-3101.
9. Wherry, E. J., and R. Ahmed. 2004. Memory CD8 T-cell differentiation during viral infection. J. Virol. 78: 5535-5545.
10. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22: 745-763.
11. + T cells during viral infection. J. Immunol. 166: 795-799.
12. Sabbagh, L., S. M. Kaech, M. Bourbonniere, M. Woo, L. Y. Cohen, E. K. Haddad, N. Labrecque, R. Ahmed, and R. P. Sekaly. 2004. The selective increase in caspase-3 expression in effector but not memory T cells allows susceptibility to apoptosis. J. Immunol. 173: 5425-5433.
13. + T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192: 63-75.
14. Champagne, P., G. S. Ogg, A. S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G. P. Rizzardi, S. Fleury, M. Lipp, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410: 106-111.
15. + T cells. Blood 101: 2711-2720.
16. + T cells. Blood 109: 2505-2513.
17. + T cells. Immunity 15: 871-882.
18. Abel, K., L. Compton, T. Rourke, D. Montefiori, D. Lu, K. Rothaeusler, L. Fritts, K. Bost, and C. J. Miller. 2003. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and α interferon responses. J. Virol. 77: 3099-3118.
19. Genescà, M., J. Li, L. Fritts, P. Chohan, K. Bost, T. Rourke, S. A. Blozis, M. B. McChesney, and C. J. Miller. 2007. Depo-provera abrogates attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239. J. Med. Primatol. 36: 266-275.
20. Miller, C. J., M. B. McChesney, X. Lu, P. J. Dailey, C. Chutkowski, D. Lu, P. Brosio, B. Roberts, and Y. Lu. 1997. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J. Virol. 71: 1911-1921.
21. Dailey, P. J., M. Zamroud, R. Kelso, J. Kolberg, and M. Urdea. 1995. Quantitation of simian immunodeficiency virus (SIV) RNA in plasma of acute and chronically infected rhesus macaques using a branched DNA (bDNA) signal amplification assay. J. Med. Primatol. 24: 209.
22. Pahar, B., J. Li, T. Rourke, C. J. Miller, and M. B. McChesney. 2003. Detection of Ag-specific T cell interferon γ expression by ELISPOT and cytokine flow cytometry assays in rhesus macaques. J. Immunol. Methods 282: 103-115.
23. Hoffmeister, B., F. Kiecker, L. Tesfa, H. D. Volk, L. J. Picker, and F. Kern. 2003. Mapping T cell epitopes by flow cytometry. Methods 29: 270-281.
24. Goulder, P. J., and D. I. Watkins. 2004. HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol. 4: 630-640.
25. Barouch, D. H., J. Powers, D. M. Truitt, M. G. Kishko, J. C. Arthur, F. W. Peyerl, M. J. Kuroda, D. A. Gorgone, M. A. Lifton, C. I. Lord, et al. 2005. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nat. Immunol. 6: 247-252.
26. + lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239δ3-vaccinated rhesus macaques. J. Virol. 79: 8131-8141.
27. Stebbings, R., J. Stott, N. Almond, R. Hull, J. Lines, P. Silvera, R. Sangster, T. Corcoran, J. Rose, S. Cobbold, et al. 1999. Mechanisms of protection induced by attenuated simian immunodeficiency virus, II: lymphocyte depletion does not abrogate protection. AIDS Res. Hum. Retroviruses 14: 1187-1198.
28. + T cells in macaques chronically infected with SIVmac251. J. Immunol. 174: 1913-1921.
29. Zimmerli, S. C., A. Harari, C. Cellerai, F. Vallelian, P. A. Bart, and G. Pantaleo. 2005. HIV-1-specific IFN-γIL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc. Natl. Acad. Sci. USA 102: 7239-7244.
30. + T cell effector activity is dictated by cognate peptide concentration. J. Immunol. 172: 6407-6417.
31. Gougeon, M. L. 2005. To kill or be killed: how HIV exhausts the immune system. Cell Death Differ. 12(Suppl. 1): 845-854.
32. Hurtrel, B., F. Petit, D. Arnoult, M. Muller-Trutwin, G. Silvestri, and J. Estaquier. 2005. Apoptosis in SIV infection. Cell Death Differ. 12(Suppl. 1): 979-990.
33. + T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL. J. Immunol. 172: 4444-4453.
34. Wang, X. Z., M. A. Brehm, and R. M. Welsh. 2004. Preapoptotic phenotype of viral epitope-specific CD8 T cells precludes memory development and is an intrinsic property of the epitope. J. Immunol. 173: 5138-5147.
35. Franco, A., D. A. Tilly, I. Gramaglia, M. Croft, L. Cipolla, M. Meldal, and H. M. Grey. 2000. Epitope affinity for MHC class I determines helper requirement for CTL priming. Nat. Immunol. 1: 145-150.